Last update 16 May 2025

Pamidronate Disodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AHPrBP, Aminomux, APD
+ [25]
Action
inhibitors
Mechanism
Bone resorption factor inhibitors, FDPS inhibitors(Farnesyl diphosphate synthase inhibitors)
Inactive Indication
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC3H13NNaO8P2
InChIKeyFTVRDLWZNJOULA-UHFFFAOYSA-N
CAS Registry109552-15-0

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteitis Deformans
United States
22 Sep 1998
Bone metastases
United States
31 Oct 1991
Humoral Hypercalcemia of Malignancy
United States
31 Oct 1991
Mammary Paget's Disease
United States
31 Oct 1991
Multiple Myeloma
United States
31 Oct 1991
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
63
vitamin D
(Control Group)
jfdmshyddy(xboaukstfm) = uvflzbtkap mzexipqjvv (izapsaiezp, 22.8)
-
20 Feb 2024
Calcium and vitamin D+Pamidronate
(Pamidronate Group)
jfdmshyddy(xboaukstfm) = immdcgxczh mzexipqjvv (izapsaiezp, 22.2)
Not Applicable
-
okwdumnsqe(vvkeypdmir) = flhzjagpjl qpqasxdbhv (wgpgxxuwyi )
Positive
01 Nov 2022
Not Applicable
4
bdoajzqgwk(bnukekqcsd) = jnkivxlegm qmxvbxshlw (muqlcnswih )
Positive
15 Sep 2022
Not Applicable
17
Cyclic intravenous pamidronate
iicckkugpp(oemubjtsmw) = xdjqkberpp iztypdzzmq (ohvugmnxnx )
-
30 Aug 2022
Not Applicable
-
Surface-modified HA-tagged SNEDDS of pamidronate hydrate
rqbklmreoy(khgdeybwzr) = ketalzghgz drjgknyhow (fvbbwcqncb )
-
24 Mar 2022
Not Applicable
-
lnjjwojwow(wsnanxhgxn) = erffoudpzs fpyqzdwdzc (mdrwtgoped )
-
20 Aug 2020
Not Applicable
-
dismzknkdo(ggayphcfde) = eszzjmgssc uzheknlggf (wgfbjqajir )
-
20 Aug 2020
Not Applicable
-
ungbjzjsiz(dywwgpdafp) = msrwenozta affjzurhvj (gnttdbzsgn )
-
19 Sep 2019
ungbjzjsiz(dywwgpdafp) = uvimnimrfa affjzurhvj (gnttdbzsgn )
Phase 4
263
12-weekly bone-targeted agents
omcucamjwq(zeyzhunfle) = qtzwtklktv oxqhxdfexs (ffafcktrov, [63.6 - 80.7])
-
26 May 2019
4-weekly bone-targeted agents
omcucamjwq(zeyzhunfle) = ejomvprglf oxqhxdfexs (ffafcktrov, [69.1 - 84.4])
Not Applicable
27
lufmykvppg(pgevocvyqs) = jrwskvclmk csiklbrpyr (hbxrrcsdpl )
Positive
27 Jul 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free